Industry context
Alvotech [ALVOW]
Pivot Data
Pivot Statistics
Next Pivot Prediction Last: $0.25
Alvotech plummets -24.27%.
Alvotech (ALVOW) stock price plummeted on Monday after the stock fell $-0.0801 (-24.27%) from the previous session on extremely light volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 0.22% rise. Yesterday's trading volume was 1 252 shares, worth about $313. This represents 1 252 shares more than the day before. Volume was below the 10-day average of 5 790 shares.
Alvotech signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-13.3%), medium- (-13.3%), and long-term (-13.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Alvotech Support & Resistance Levels
The stock is trading above the closest support level at $0.230. approximately $0.0200 (8.00%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s10.23 -
Alvotech Evaluation
- Short score: -1.43
- Medium score: -2.21
- Long score: -2.36
Relationship map
Correlation snapshot
Positioning pressure
Short interest pressure
Short positioning does not currently stand out as a dominant risk factor.
Updated 2026-05-29News flow
Latest company news
Market coverage
seekingalpha.com Alvotech (ALVO) Q1 2026 Earnings Call Transcript May 7, 2026 defenseworld.net Alvotech (NASDAQ:ALVOW) Sees Significant Decrease in Short Interest Mar 28, 2026 defenseworld.net Short Interest in Alvotech (NASDAQ:ALVOW) Increases By 32.7% Feb 16, 2026 defenseworld.net Alvotech (NASDAQ:ALVOW) Stock Price Down 20.3% – Here’s What Happened Jan 15, 2026Company context
Company profile
Alvotech Holdings SA is an Icelandic enterprise that operating via its subsidiary companies undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption
Navigation